巴楚医学

参考文献

[1]汪明月，童翠玲．血管内导管相关性血流感染的危险因素研究进展[J]．临床护理杂志，2019,18(1):60-64．

[2]Zwiech R,Adelt M,Chrul S.A taurolidine-citrateheparin lock solution effectively eradicates pathogens from the catheter biofilm in hemodialysis patients[J].Am J Ther,2016,23(2):e363-e368．

[3]Sofroniadou S,Revela I,Kouloubinis A,et al.Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients:aprospective randomized study[J].Hemodial Int,2017,21(4):498-506．

[4]韩建华．ICU病房导管相关性血流感染的临床流行病学调查[J]．中国社区医师，2018,34(26):81-82．

[5]武迎宏，曹煜隆，周春莲，等．中央导管相关血流感染经济损失的病例对照研究[J]．中华医院感染学杂志，2018,28(17):2615-2617．

[6]Gorski L A.Infusion nursing standards of practice[J].J Infus Nurs,2007,30(3):151-152．

[7]Zacharioudakis I M,Zervou F N,Arvanitis M,et al.Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections:a meta-analysis of randomized controlled trials[J].Clin Infect Dis,2014,59(12):1741-1749．

[8]Zakhour R,Chaftari A M,Raad I I.Catheter-related infections in patients with haematological malignancies:novel preventive and therapeutic strategies[J].Lancet Infect Dis,2016,16(11):e241-e250．

[9]O'Grady N P,Alexander M,Dellinger E P,et al.Summary of recommendations:guidelines for the prevention of intravascular catheter-related infections[J].Clin Infect Dis,2011,52(9):1087-1099．

[10]田磊，周挺，马爱霞，等．预充式导管冲洗器临床效果Meta分析[J]．中国护理管理，2017,17(11):1545-1555．

[11]王会英，朱玄，徐泰民，等．预充式导管冲洗器用于中心静脉导管封管的临床效果研究[J]．护士进修杂志，2017,32(13):1232-1234．

[12]Luiz M V S J,Scavone C,Tzanno C.The CLOCK trial,a double-blinded randomized controlled trial:Trisodium citrate 30%and minocycline 3 mg/mL plus EDTA 30mg/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis[J].Hemodial Int,2017,21(2):294-304．

[13]孙岩，辛海南．不同浓度肝素钠封管液在血液透析中心静脉导管患者中的效果观察[J]．中国急救医学，2016,36(11):189-190．

[14]王娟．抗生素锁技术治疗中心静脉导管相关感染的实验室研究[D]．长江大学，2015．

[15]Dixon J J,Steele M,Makanjuola A D.Anti-microbial locks increase the prevalence of staphylococcus aureus and antibiotic-resistant Enterobacter:observational retrospective cohort study[J].Nephrol Dial Transplant,2012,27(9):3575-3581．

[16]Moghaddas A,Abbasi M R,Gharekhani A,et al.Prevention of hemodialysis catheter-related blood stream infections using a cotrimoxazole-lock technique[J].Future Microbiol,2015,10(2):169-178．

[17]郑艳，吴君，李莉，等．中心静脉集束化干预策略预防导管相关性血流感染的Meta分析[J]．护理学报，2016,23(8):56-60．

[18]鄢成静，熊楠楠，于洋，等．庆大霉素联合肝素封管治疗长期透析导管相关血流感染疗效观察[J]．中国血液净化，2018,17(5):346-351．

[19]高艳玲，张茜雯．阿米卡星封管液在肿瘤病人中心静脉导管相关性血流感染中的应用研究[J]．全科护理，2017,15(21):2607-2609．

[20]薛娅．去甲万古霉素封管预防重症患者中心静脉导管相关性感染的临床分析[J]．北方药学，2017,14(2):194-195．

[21]敖薪，王娟．抗生素锁技术在治疗中心静脉导管相关性感染中的应用研究[J]．中华医院感染学杂志，2016,26(23):5433-5435．

[22]Souweine B,Lautrette A,Gruson D,et al.Ethanol lock and risk of hemodialysis catheter infection in critically ill patients.A randomized controlled trial[J].Am J Respir Crit Care Med,2015,191(9):1024-1032．

[23]Msakni N,Galmier M,Couret M,et al.Complementary mass spectrometric approaches and scanning electron microscopy to study the structural stability of polyurethane tunneled dialysis catheters after exposure to ethanol solutions[J].Rapid Commun Mass Sp,2013,27(21):2343-2354．

[24]Landry D L,Jaber R A,Hanumanthappa N,et al.Effects of prolonged ethanol lock exposure to carbothane-and silicone-based hemodialysis catheters:a 26-week study[J].J Vasc Access,2015,16(5):367-371．

[25]张慧，李夏卉，叶艳胜，等．乙醇封管对导管相关性血流感染预防效果的Meta分析[J]．中华医院感染学杂志，2017,27(18):4159-4162．

[26]Noelting J,Jurewitsch B,Allard J.Non-antibiotic antimicrobial catheter lock solutions in patients on home parenteral nutrition[J].Nutrients,2018,10(9):1165．

[27]Oliveira C,Nasr A,Brindle M,et al.Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition:a meta-analysis[J].Pediatrics,2012,129(2):318-329．

[28]Schilcher G,Schlagenhauf A,Schneditz D,et al.Ethanol causes protein precipitation-new safety issues for catheter locking techniques[J].PLoS One,2013,8(12):1-8．

[29]Mermel L A,Alang N.Adverse effects associated with ethanol catheter lock solutions:a systematic review[J].J Antimicrob Chemother,2014,69(10):2611-2619．

[30]Longo R,Llorens M,Goetz C,et al.Taurolidine/citrate lock therapy for primary prevention of catheter-related infections in cancer patients:results of a prospective,021randomized,phase IV trial(ATAPAC)[J].Oncology,2017,93(2):99-105．

[31]Liu H,Liu H,Deng J,et al.Preventing Catheter-related bacteremia with taurolidine-citrate catheter locks:a systematic review and meta-analysis[J].Blood Purificat,2014,37(3):179-187．

[32]Tribler S,Brandt C F,Petersen A H,et al.Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support:a randomized,placebo-controlled trial[J].Am J Clin Nutr,2017,106(3):839-848．

[33]Olthof E D,Versleijen M W,de Waal G H,et al.Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions[J].PLoS One,2014,9(11):1-9．

[34]Wouters Y,Roosenboom B,Causevic E,et al.Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock:a long-term cohort study[J].Clin Nutr,2018,38(5):1-9．

[35]赵尚平，欧好，彭玥，等．局部枸橼酸钠抗凝技术在重症监护病房高出血风险患者血液净化治疗中的作用[J]．中南大学学报（医学版），2016,41(12):1334-1339．

[36]赵宇亮，杨济桥，张凌，等．枸橼酸和肝素封管液预防血液透析长期留置导管相关感染的Meta分析[J]．中华肾脏病杂志，2013,29(8):574-582．

[37]Correa Barcellos F,Pereira Nunes B,Jorge Valle L,et al.Comparative effectiveness of 30%trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters:a randomized controlled trial(CITRIM trial)[J].Infection,2017,45(2):139-145．

[38]Kanaa M,Wright M J,Akbani H,et al.Cathasept line lock and microbial colonization of tunneled hemodialysis catheters:a multicenter randomized controlled trial[J].Am J Kidney Dis,2015,66(6):1015-1023.